The pharmacokinetics of AL-226, a new semi-synthetic cephalosporin, were studied after i. 
AL-226, the potassium salt of 7-[D-(x-hydroxy-x-phenylacetamide)j-3-methyl-3-cephem-carboxylic acid, is a new semi-synthetic cephalosporin derived from 7-amino-deacetoxycephalosporanic acid; its structure is shown in Fig. 1 . This antibiotic has an wide spectrum of activity; and is effective against The principal aim of this paper is to establish the phartnacokinetic parameters of AL-226 as a function of the dose after intravenous and intramuscular administrations. 
Animals
The rabbits used in this study were New Zealand white adult males weighing 1.5~2.5 kg.
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Bolus intravenous administration
The animals used underwent cannulation of the carotid artery following anesthesia with an intravenous dose of 30 mg/kg body weight sodium pentobarbital1).
Once the animals had recovered and were awake, AL-226 in the form of its potassium salt, dissolved in 0.5 ml of sterile distilled water was administered in doses of 10, 20, 30 and 40 mg/kg to a total of 28 rabbits (7 different ones for each dose) through the marginal ear vein. Heparinized blood samples were withdrawn at 0 (immediately before administration of the antibiotic), 3, 5, 10, 15, 20, 25, 30, 45, 60, 90 and 120 minutes after administration of the drug. Plasma was separated by centrifugation and was used to assay antimicrobial activity.
The bladders of another series of rabbits (10 different animals for each dose) were emptied and following this, after administration of the antibiotic, urine samples were taken through a direct and permanently fixed catheter at intervals of 0~1, 1~2, 2~3, 3~4 and 4~5 hours. Urine samples were brought to a pH of 7.0 by addition of SoRENSEN'S phosphate buffer.
Rabbits were operated under anesthetic with sodium pentobarbital and the biliary ducts were cannulated with polyethylene tubes for collecting the bile samples still under anesthetic of another 16 animals (4 different rabbits for each dose) at intervals of 0~0.5, 0.5~1.0, 1.0~1.5, 1.5~2.0, 2.0~3.0, 3.0~4.0 hours. Bile samples were brought to a pH of 7.0 by addition of SORENSEN's phosphate buffer.
Intramuscular administration
Another group of 24 rabbits (6 different ones each dose) was used, to which 10, 20, 30 and 40 mg/ kg body weight of the potassium salt of AL-226 dissolved in 0.5 ml of sterile distilled water were administered intramuscularly. The animals in this series underwent the same operation as those described in intravenous administration in order to obtain heparinized blood samples at intervals of 0, 3, 5, 7, 10, 12, 15, 20, 25, 30, 40, 50, 70, and 90 minutes after administration.
Plasma separated by centrifugation was again used for the assay of antimicrobial activity.
Microbiological assay
Concentrations of the antibiotic of each sample (plasma, urine, bile) were determined by an agar disc plate method6)using Bacillus subtilis (ATCC 6633) as the test organism. All assays were repeated a minimum of 4 times.
Results
Intravenous Administration CAL-226=A0*e-at+B0-e-bt (1) The parameters of the equation (1) for AL-226 are shown in Table 1 , together with the values of the distribution constants to and from the peripheric compartment, (K12, K21) the elimination constant of the antibiotic (K13), the plasma half life during the rapid and slow disposition phases (t1/2a, t1/2/3), and also the apparent distribution volumes of the central (Vc), and peripheric (Vp) compartments7).
As the parameters y and /3 were calculated from regression lines (a being obtained by method of residuals and /3 from the slow disposition phase of the plasma levels curve), we have made a statistical comparison of the difference between the slopes of the rapid disposition phase for the doses that were administered and also between the slopes of the slow disposition phase for the doses that were administered by means of the t-test14). When p=0.05, there are no statistically significant differences There exists a relationship in the form of a linear regression between the logarithm of the percentage of the dose which is still to be excreted (Umax-Ut) and the interval of excretion of all the doses that were studied, the equations obtained being shown in Table 2 .
The significance of the relation between the two variables is given by the F-test of regression and the results show that the F-values (regression F is very significant and the F of deviation from linear regression is not significant) are acceptable for all the doses. This table also shows the values of the urinary excretion constant (Ku) calculated from the corresponding equations. The drug plasma concentration-time curves may be defined to be the following equation12):
where f is the bio-availability, t' is the latency period (2.03 min., 2.24 min., 1.06 min., 2.09 min., for Discussion AL-226 administered by intravenous bolus injections to rabbits shows a rapid and slow disposition constant (a and /3) together with the corresponding plasma half-lives which are not altered in the interval of the doses studied. The speed of distribution into the peripheric compartment is less than the speed of return to the central compartment (K12/K21=0.52) steady state being reached in a relatively short time (K12/K13=0.35) and being distributed in a small volume of the peripheric cornpartment, since Vc> Vpfor all doses. The retention of AL-226 in the peripheric compartment is limited due to the low value of Vp. This kinetic behaviour of AL-226 is very different from that found by YAMAZAKI et al. 15 )for cefalexin and SCE-100 under the same experimental conditions at doses of 10 mg/kg administered intravenously where the relationship K12/K21=7.52 for the former and 4.23 for the latter, Vcbeing much smaller than Vpin both cases.
As for other drugs, we have found the following linear relationships10,11): C0 =4.12±0.102x j=dose in mg/kg.
This relationship allows us to find the parameter for doses up to 40 mg/kg which have not been studied. The values of C0calculated from experimental data for cephalexin, and SCE-100 was 16.9pg/ml and 16.61rg/ml respectively, at a dose of 10 mg/kg, that is 2.43 times lower than that found for AL-226. However, while for AL-226, after 2 hours and at greater doses, no antibiotic may be detected in plasma, appreciable concentrations of the other cephalosporins may be detected in plasma after 6 hours.
Under our constant experimental conditions, comparing with the experimental results obtained by HARADA et al.4)it may be seen that AL-226 has an elimination phase which is very similar to that of cephalothin for doses of 10 and 20 mg/kg.
The total values excreted in urine, expressed as percentage of dose for AL-226 at a dose of 10 mg/ kg are similar to those found by YAMAZAKI et al. 15 )for cephalexin and SCE-100 after 6 hours. While at a dose of 20 mg/kg it is 1.44 times lower than that found for cefazolin and ceftezole4)after 6 hours.
The fact that the constant of the elimination phase of i.v. administration(')is slightly greater than the apparent elimination constant Kuis explainable if we bear in mind that AL-226 is excreted in VOL. XXXII NO. 5  THE  JOURNAL  OF ANTIBIOTICS bile, although however, it is inferior to that obtained for cephalexin and SCE-100. AL-226 is rapidly absorbed when administered intramuscularly as may be seen from the fact that the maximum of the plasma concentrations is reached after 15 minutes for all doses except for 20 mg/kg, which is reached 20 minutes after administration of the antibiotic, after which a rapid decrease is observable for all doses. However, the antibiotic in active form was found in plasma 90 minutes after intramuscular administration at doses of 20, 30 and 40 mg/kg. Under our same conditions, the maximum plasma level reached for cefazolin and cephalothin was greater than that of AL-226 at a dose of 20 mg/kg4).
